Literature DB >> 12932139

Antifungal agents from the roots of Cudrania cochinchinensis against Candida, Cryptococcus, and Aspergillus species.

Toshio Fukai1, Makiko Yonekawa, Ai-Jun Hou, Taro Nomura, Han-Dong Sun, Jun Uno.   

Abstract

Bioassay-guided fractionation resulted in the isolation of four antifungal agents from the roots of Cudrania cochinchinensis. Two of these were new compounds, cudraxanthone S [1, 1,3,5,6-tetrahydroxy-2-(1,1-dimethyl-2-propenyl)xanthone] and cudraflavanone B (2, 2',4',5,7-tetrahydroxy-6-prenylflavanone). The remaining two compounds were known compounds, toxyloxanthone C (3) and wighteone (4). Among these compounds, 1, 3, and 4 exhibited antifungal activities against Cryptococcus neoformans, Aspergillusfumigatus, and A. nidulans (MICs = 2-8 microg/mL). Compounds 1 and 3 also showed antifungal activity against Candida glabrata (MICs = 4-8 microg/mL).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932139     DOI: 10.1021/np030024u

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Cudraflavanone B Isolated from the Root Bark of Cudrania tricuspidata Alleviates Lipopolysaccharide-Induced Inflammatory Responses by Downregulating NF-κB and ERK MAPK Signaling Pathways in RAW264.7 Macrophages and BV2 Microglia.

Authors:  Wonmin Ko; Kwan-Woo Kim; Tran Hong Quang; Chi-Su Yoon; Nayeon Kim; Hwan Lee; Sam-Cheol Kim; Eun-Rhan Woo; Youn-Chul Kim; Hyuncheol Oh; Dong-Sung Lee
Journal:  Inflammation       Date:  2021-02       Impact factor: 4.092

2.  Efficacy of some natural compounds as antifungal agents.

Authors:  Sudha Vengurlekar; Rajesh Sharma; Piyush Trivedi
Journal:  Pharmacogn Rev       Date:  2012-07

3.  Action of Coriandrum sativum L. Essential Oil upon Oral Candida albicans Biofilm Formation.

Authors:  V F Furletti; I P Teixeira; G Obando-Pereda; R C Mardegan; A Sartoratto; G M Figueira; R M T Duarte; V L G Rehder; M C T Duarte; J F Höfling
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-21       Impact factor: 2.629

4.  Wighteone exhibits an antitumor effect against EGFR L858R/T790M mutation non-small cell lung cancer.

Authors:  Peiyuan Sun; Yana Qu; Yuna Wang; Jing Wang; Xuanjun Wang; Jun Sheng
Journal:  J Cancer       Date:  2021-05-05       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.